TIDMSILF

RNS Number : 7722R

Silver Falcon PLC

26 September 2017

Silver Falcon Plc

(to become Hemogenyx Pharmaceuticals Plc)

Investor presentations

Silver Falcon Plc, (LSE: SILF), which has agreed to acquire the biotechnology company Hemogenyx Pharmaceuticals Limited ("Hemogenyx"), announces that it will be holding a series of meetings with investors regarding the opportunity presented to shareholders by the proposed acquisition of Hemogenyx LLC ("Hemogenyx").

The presentation will be led by Chief Executive Officer & Co-Founder of Hemogenyx, Dr Vladislav Sandler, with other Proposed Directors available for discussions after the formal presentation. The same presentation will be given at all events which are being held at different times to offer convenient options for those wishing to attend.

3 October 2017 - Lunchtime presentation hosted by Peterhouse Corporate Finance Limited

 
 Time:       12.30pm - a sandwich lunch will be provided 
 Location:   3(rd) Floor New Liverpool House, 15 Eldon Street, London 
              EC2M 7LD

3 October 2017 - Afternoon Presentation hosted by Shard Capital Partners LLP

 
 Time:       5pm - the presentation will be followed by drinks and 
              canapes 
 Location:   23(rd) Floor, 20 Fenchurch Street, London EC3M 3BY

4 October 2017 - Evening presentation hosted by Optiva Securities Limited

 
 Time:       6pm - the presentation will be followed by drinks and 
              canapes 
 Location:   Sartoria, 20 Savile Row, London W1S 3PR

For more information on the proposed acquisition see the Latest News section on: www.silverfalconplc.com

For a short video by Dr Sandler on Hemogenyx click here: www.brrmedia.co.uk/event/160159

If you would like to register for any of the investor presentations, or require further information, please contact Lianne Cawthorne at Walbrook PR on 020 7933 8780 or email hemogenyx@walbrookpr.com ensuring you detail in your email which presentation you would like to attend.

 
 Hemogenyx Pharmaceuticals Limited                                                                             www.hemogenyx.com 
 Peter Redmond, Director                                                                                         Via Walbrook PR 
 
 Optiva Securities Ltd                                                                                  Tel: +44 (0)20 3137 1902 
 Christian Dennis 
 
 Shard Capital Partners LLP                                                                             Tel: +44 (0)20 7186 9950 
 Damon Heath, Erik Woolgar 
 
 Peterhouse Corporate Finance Limited                                                                   Tel: +44 (0)20 7469 0930 
 Lucy Williams/Duncan Vasey 
 
 Walbrook PR                                                                Tel: +44 (0)20 7933 8780 or hemogenyx@walbrookpr.com 
 Paul McManus                                                                                           Mob: +44 (0)7980 541 893 
 
 Flowcomms IR                                                                    Mob: +44 (0)7891 627 441 or sasha@flowcomms.com 
 Sasha Sethi

This information is provided by RNS

The company news service from the London Stock Exchange

END

MSCEAFNSALLXEAF

(END) Dow Jones Newswires

September 26, 2017 02:01 ET (06:01 GMT)

Silver Falcon (LSE:SILF)
Historical Stock Chart
From Apr 2024 to May 2024 Click Here for more Silver Falcon Charts.
Silver Falcon (LSE:SILF)
Historical Stock Chart
From May 2023 to May 2024 Click Here for more Silver Falcon Charts.